Clinical Trials

VGI Health Technology Limited (NSX:VTL) New Partnership

🕔2/14/2024 3:08:00 PM

VGI Health Technology Limited (NSX:VTL) is pleased to announce that it has entered into a non-binding Heads of Agreement with Hebei Visual Medical Technology Co. Ltd, marking a significant step in VTL's distribution strategy into the market of the People's Republic of China.

Read Full Article

VGI Health Technology Limited (NSX:VTL) HREC Approval for Phase II Clinical Study

🕔1/11/2024 9:04:00 AM

VGI Health Technology Limited (NSX:VTL) is pleased to announce that its wholly owned subsidiary, Invictus Ops Pty Ltd, has received human ethics approval from the Human Research Ethics Committee of The Peter MacCallum Cancer Centre for its Phase II clinical study in Pancreatic Cancer.

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) OxiDx Platform Technology Secures Patent in Japan

🕔9/4/2023 8:12:36 AM

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce that its subsidiary OxiDx Pty Ltd has been granted a patent in Japan for its platform technology to measure oxidative stress.

Read Full Article

VGI Health Technology Limited (NSX:VTL) commences divestment of Invictus BioPharma Pty Ltd

🕔8/29/2023 11:16:00 AM

VGI Health Technology Limited (NSX:VTL) commences divestment of Invictus BioPharma Pty Ltd

Read Full Article

VGI Health Technology Limited (NSX:VTL) Quarterly Update

🕔1/31/2023 8:42:00 AM

The Directors of VGI Health Technology Limited (NSX:VTL) are pleased to provide the following update for the quarter ending 31 December 2022.

Read Full Article

VGI Health Technology Limited (NSX:VTL) Update on Sale of Invictus BioPharma

🕔12/21/2022 4:05:00 PM

On 5 April 2022, the Directors of VGI Health Technology Limited (NSX:VTL) announced the sale of its wholly owned subsidiary, Invictus BioPharma Pty Ltd to Invictus BioPharma Holdings Ltd (IVBHL) (the Transaction).

Read Full Article

VGI Health Technology Limited (NSX:VTL) R & D Facility Agreement with Fundsquire Pty Ltd

🕔10/13/2022 3:26:00 PM

VGI Health Technology Limited (NSX:VTL) is pleased to announce that it has entered into an R&D Loan Facility Agreement (Loan Facility) with Fundsquire Pty Ltd.

Read Full Article